Immune-Regulatory Mechanisms of Classical and Experimental Multiple Sclerosis Drugs: A Special Focus on Helminth-Derived Treatments

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|11|1152-1170

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.11, 2016-04, pp. : 1152-1170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 610-623

Bentham Science Publishers

Access to resources Recommend Favorite

Immune-Regulatory Transcriptional Responses in Multiple Organs of Atlantic Salmon After Tributyltin Exposure, Alone or in Combination with Forskolin

By Pavlikova Nela   Arukwe Augustine  

Journal of Toxicology and Environmental Health, Vol. 74, Iss. 7-9, 2011-01 ,pp. : 478-493

Taylor & Francis Ltd

Access to resources Recommend Favorite

Epigenetic Drugs for Multiple Sclerosis

By  

Current Neuropharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. : 3-9

Bentham Science Publishers

Access to resources Recommend Favorite

Remyelinating and neuroprotective treatments in multiple sclerosis

By Stangel Martin  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 331-347

Informa Healthcare

Access to resources Recommend Favorite

Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4513-4517

Bentham Science Publishers

Access to resources Recommend Favorite